Summary

Report Overview
The Global Hydrocolloids Market reached US$ 11.32 billion in 2023 and is expected to reach US$ 17.78 billion by 2031 growing with a CAGR of 5.8% during the forecast period 2024-2031.
Hydrocolloids are colloidal systems where hydrophilic polymers are dispersed in water. These polymers can originate from various sources, including vegetable, animal, microbial, or synthetic origins, and they typically contain numerous hydroxyl groups, which enhance their ability to bind water. The presence of water in varying amounts allows hydrocolloids to exist in different states, such as gels or solutions, depending on the concentration and conditions of the environment.
Hydrocolloid dressings are widely used in clinical settings for various types of wounds due to their ability to create a moist healing environment, absorb exudate, and protect the wound from external contaminants. These dressings contain hydrophilic polymers that form a gel when they come into contact with wound fluid, providing several benefits.
The gel layer created by the hydrocolloid dressing helps maintain a moist environment around the wound, which is crucial for optimal healing. Moisture promotes cell migration, proliferation, and the formation of new tissue, accelerating the healing process.
Market Dynamics: Drivers
Rising incidence of wounds & surgical procedures
The demand for the global hydrocolloids market is driven by multiple factors. One of the primary factors is the rising incidence of wounds & surgical procedures. The increasing number of acute and chronic wounds, particularly among aging populations, is a significant driver of the hydrocolloid market.
Surgical wounds can vary in complexity, from minor incisions to extensive procedures that leave larger, more complex wounds. Hydrocolloid dressings are particularly effective for managing these wounds due to their ability to maintain a moist environment, which is crucial for healing. The number of surgical procedures is the vast population of patients requiring wound care. Each surgery entails a risk of complications, including infections and delayed healing, making effective wound management essential.
Moreover, key players in the industry have technological advancements and product launches that would drive this market growth. Innovations in hydrocolloid dressings include the integration of antimicrobial agents. These agents help prevent infections, a common complication in wound care. By reducing the microbial load at the wound site, antimicrobial hydrocolloid dressings can enhance healing rates and decrease the incidence of wound-related infections.
Also, in August 2023, Scapa Healthcare successfully assisted a global consumer company in launching a hydrocolloid-based medical device in record time. The company aimed to introduce a new medical-grade, skin-friendly hydrocolloid product but lacked the regulatory expertise and capabilities to develop it internally.
Restraints
Factors such as allergic reactions & skin irritations associated with the patches, high cost compared to traditional dressings, and lack of clinical knowledge and training are expected to hamper the market.
Market Segment Analysis
The global hydrocolloids market is segmented based on type, application, end-user, and region.
The burns segment accounted for approximately 54.2% of the global hydrocolloids market share
The burns segment is expected to hold the largest market share over the forecast period. Hydrocolloid dressings are particularly effective in managing burn wounds due to their ability to create and maintain a moist healing environment.
The moisture provided by hydrocolloid dressings plays a crucial role in creating an optimal microenvironment for cell migration, which is essential for wound healing. In a moist environment, cells such as fibroblasts and keratinocytes can more easily move across the wound bed, promoting the formation of granulation tissue and re-epithelialization, ultimately accelerating the overall healing process.
Moreover, key players in the industry product launch that would propel this market growth. For instance, one of the major players Cardinal Health Hydrocolloid Dressing is an advanced wound care product specifically designed to maintain a moist healing environment, which is crucial for effective wound management. This dressing is particularly suitable for various types of wounds, including pressure ulcers, minor burns, and post-operative wounds.
Similarly, 3M introduced the 3M Tegaderm hydrocolloid dressing, Nexcare hydrocolloid, and 3M Nu-Derm standard hydrocolloid dressings are helped to drive this market growth.
Also, other players in the industry introduced the BAND-AID Brand HYDRO SEAL Purpose Hydrocolloid Gel Bandages offer a comprehensive solution for treating minor wounds, providing six key benefits in a single bandage.
Market Geographical Share
North America accounted for approximately 43.1% of the global hydrocolloids market share
North America region is expected to hold the largest market share over the forecast period. The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, significantly drives the hydrocolloids market, particularly in wound care. Chronic wounds present unique challenges in healing and require specialized dressings that can effectively manage moisture levels and promote healing. Hydrocolloid dressings are particularly effective for these purposes, leading to increased demand in the healthcare sector.
Moreover, North America has a growing aging population, which is more susceptible to chronic conditions and wounds. Technological advancements, rising healthcare expenditure, and favorable reimbursement policies are helping to drive this market growth.
For instance,  3M, a leading manufacturer of medical products, announced the launch of a new line of advanced hydrocolloid dressings designed specifically for managing chronic wounds. This innovative product line is expected to have a significant impact on the hydrocolloids market in North America, reflecting 3M's commitment to driving progress in wound care technology.
In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, and key player manufacturers in the hydrocolloids driving this market growth. For instance, in  Las Vegas Regenerex in September 2023, Pharma, Inc. announced the formation of its comprehensive management team and plans to start manufacturing operations in the fourth quarter of 2023. The company specializes in wound care products that utilize proprietary formulas aimed at healing wounds quickly, thereby reducing the risk of complications. 
Clinical evaluations have demonstrated that 95% of chronic wounds treated with their products achieved complete closure within 90 days. All products incorporate Regenerex's unique QBx ingredients, which help create an optimal environment for wound healing. Modern wound dressings like hydrocolloids and collagen-based products are designed to absorb wound exudate, but they go beyond just covering and protecting the wound area.
Market Segmentation
By Type 
Sterile
Non-Sterile
By Application 
Burns
Chronic Wounds
Surgical Wounds
Necrotic Wounds
Others
By End-User 
Hospitals
Specialty Clinics
Ambulatory Surgical Centres
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the hydrocolloids market include 3M, Amparo medical Technologies., Scapa, Sarasota Medical Products, Cardinal Health., Convatec, Fralock LLC, Hi Tech Products., AMERX Health Care, and DermaRite Industries, LLC. Among others.
Key Developments
In June 2024, The INKEY List launched its Hydrocolloid Invisible Pimple Patches, marking its entry into the pimple patch market. These patches are designed to help reduce the appearance of breakouts, particularly whiteheads, by utilizing hydrocolloid technology combined with active ingredients like salicylic acid. According to Dr. Joshua Zeichner, hydrocolloids are effective because they protect the outer skin layer, absorb excess fluid, and promote healing.
In April 2021, Scapa Healthcare announced enhancements at its Hydrocolloid Technology Center in Orangeburg, New York, as part of its commitment to meeting the increasing global demand for premium medical-grade hydrocolloid adhesive technologies. This facility specializes in the design, development, and manufacturing of hydrocolloid formulations used in various applications, including advanced wound care, ostomy care, and consumer wellness products.
Why Purchase the Report?
To visualize the global hydrocolloids market segmentation based on type, application, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development. 
Excel data sheet with numerous data points on the hydrocolloids market in all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.
The global hydrocolloids market report would provide approximately 62 tables, 54 figures, and 183 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Incidence of Wounds & Surgical Procedures
4.1.2. Restraints
4.1.2.1. Allergic Reactions & Skin Irritations Associated with the Patches
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Sterile *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Sterile
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Burns*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Wounds
7.4. Surgical Wounds
7.5. Necrotic Wounds
7.6. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centres
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. 3M *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Amparo medical Technologies.
11.3. Scapa
11.4. Sarasota Medical Products
11.5. Cardinal Health.
11.6. Convatec
11.7. Fralock LLC
11.8. Hi-Tech Products.
11.9. AMERX Health Care
11.10. DermaRite Industries, LLC. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us